pancan.ai/Ask
Recruiting phase 3 KRAS trials
25 trials match; 14 of those shown are recruiting or about to. NCT07656376↗ NCT07689539↗ NCT07805954↗ NCT07562152↗ NCT07621718↗ NCT06998940↗ +19 more below
Computed from the knowledge API (findTrials); every record links to its source.
| Trial | Phase | Outcome | Status | Start | Sponsor |
|---|---|---|---|---|---|
| NCT07656376↗ Clinical Trial of DN022150 Combined With AG Chemotherapy as First-line Treatment for Locally Advanc… | Phase 2 / Phase 3 | Ongoing | Not yet recruiting | 2027-06 | Jiangxi Kvvit Pharmaceutical Co., Ltd. |
| NCT07689539↗ Trial of DN022150 Versus Chemotherapy in Previously Treated Advanced Pancreatic Cancer With KRAS G1… | Phase 3 | Ongoing | Not yet recruiting | 2026-09 | Jiangxi Kvvit Pharmaceutical Co., Ltd. |
| NCT07805954↗ Study of Zoldonrasib (RMC-9805) Plus Daraxonrasib (RMC-6236) Versus Gemcitabine and Nab-Paclitaxel … | Phase 3 | Ongoing | Recruiting | 2026-08 | Revolution Medicines, Inc. |
| NCT07562152↗ Atebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma | Phase 3 | Ongoing |